These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

909 related articles for article (PubMed ID: 28511573)

  • 1. Inhibition of PKR ameliorates lipopolysaccharide-induced acute lung injury by suppressing NF-κB pathway in mice.
    Li Y; Xiao J; Tan Y; Wang J; Zhang Y; Deng X; Luo Y
    Immunopharmacol Immunotoxicol; 2017 Aug; 39(4):165-172. PubMed ID: 28511573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Syringic acid attenuates acute lung injury by modulating macrophage polarization in LPS-induced mice.
    Wang WT; Zhang YY; Li ZR; Li JM; Deng HS; Li YY; Yang HY; Lau CC; Yao YJ; Pan HD; Liu L; Xie Y; Zhou H
    Phytomedicine; 2024 Jul; 129():155591. PubMed ID: 38692075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of acteoside on lipopolysaccharide-induced inflammation in acute lung injury via regulation of NF-κB pathway in vivo and in vitro.
    Jing W; Chunhua M; Shumin W
    Toxicol Appl Pharmacol; 2015 Jun; 285(2):128-35. PubMed ID: 25902336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cavidine Ameliorates Lipopolysaccharide-Induced Acute Lung Injury via NF-κB Signaling Pathway in vivo and in vitro.
    Niu X; Liu F; Li W; Zhi W; Zhang H; Wang X; He Z
    Inflammation; 2017 Aug; 40(4):1111-1122. PubMed ID: 28365871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kegan Liyan oral liquid ameliorates lipopolysaccharide-induced acute lung injury through inhibition of TLR4-mediated NF-κB signaling pathway and MMP-9 expression.
    Zhang X; Sun CY; Zhang YB; Guo HZ; Feng XX; Peng SZ; Yuan J; Zheng RB; Chen WP; Su ZR; Huang XD
    J Ethnopharmacol; 2016 Jun; 186():91-102. PubMed ID: 27036629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downregulated microRNA-27b attenuates lipopolysaccharide-induced acute lung injury via activation of NF-E2-related factor 2 and inhibition of nuclear factor κB signaling pathway.
    Huang Y; Huang L; Zhu G; Pei Z; Zhang W
    J Cell Physiol; 2019 May; 234(5):6023-6032. PubMed ID: 30584668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acanthoic acid ameliorates lipopolysaccharide-induced acute lung injury.
    Qiushi W; Guanghua L; Guangquan X
    Eur J Pharmacol; 2015 Mar; 750():32-8. PubMed ID: 25620130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mogroside IIIE Attenuates LPS-Induced Acute Lung Injury in Mice Partly Through Regulation of the TLR4/MAPK/NF-κB Axis via AMPK Activation.
    Tao L; Cao F; Xu G; Xie H; Zhang M; Zhang C
    Phytother Res; 2017 Jul; 31(7):1097-1106. PubMed ID: 28512854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular hydrogen ameliorates lipopolysaccharide-induced acute lung injury in mice through reducing inflammation and apoptosis.
    Xie K; Yu Y; Huang Y; Zheng L; Li J; Chen H; Han H; Hou L; Gong G; Wang G
    Shock; 2012 May; 37(5):548-55. PubMed ID: 22508291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isotetrandrine protects against lipopolysaccharide-induced acute lung injury by suppression of mitogen-activated protein kinase and nuclear factor-kappa B.
    Liang XM; Guo GF; Huang XH; Duan WL; Zeng ZL
    J Surg Res; 2014 Apr; 187(2):596-604. PubMed ID: 24331940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective effects of polydatin on lipopolysaccharide-induced acute lung injury through TLR4-MyD88-NF-κB pathway.
    Jiang Q; Yi M; Guo Q; Wang C; Wang H; Meng S; Liu C; Fu Y; Ji H; Chen T
    Int Immunopharmacol; 2015 Dec; 29(2):370-376. PubMed ID: 26507165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ulinastatin inhibits the inflammation of LPS-induced acute lung injury in mice via regulation of AMPK/NF-κB pathway.
    Li W; Qiu X; Jiang H; Zhi Y; Fu J; Liu J
    Int Immunopharmacol; 2015 Dec; 29(2):560-567. PubMed ID: 26481965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective anti-inflammatory activity of tovophyllin A against acute lung injury and its potential cytotoxicity to epithelial lung and breast carcinomas.
    El-Agamy DS; Mohamed GA; Ahmed N; Elkablawy MA; Elfaky MA; Elsaed WM; Mohamed SGA; Ibrahim SRM
    Inflammopharmacology; 2020 Feb; 28(1):153-163. PubMed ID: 31218570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Saikosaponin a Ameliorates LPS-Induced Acute Lung Injury in Mice.
    Du ZA; Sun MN; Hu ZS
    Inflammation; 2018 Feb; 41(1):193-198. PubMed ID: 28986747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diosmin downregulates the expression of T cell receptors, pro-inflammatory cytokines and NF-κB activation against LPS-induced acute lung injury in mice.
    Imam F; Al-Harbi NO; Al-Harbi MM; Ansari MA; Zoheir KM; Iqbal M; Anwer MK; Al Hoshani AR; Attia SM; Ahmad SF
    Pharmacol Res; 2015 Dec; 102():1-11. PubMed ID: 26361726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pretreatment with the compound asperuloside decreases acute lung injury via inhibiting MAPK and NF-κB signaling in a murine model.
    Qiu J; Chi G; Wu Q; Ren Y; Chen C; Feng H
    Int Immunopharmacol; 2016 Feb; 31():109-15. PubMed ID: 26710167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Puerarin prevents LPS-induced acute lung injury via inhibiting inflammatory response.
    Wang X; Yan J; Xu X; Duan C; Xie Z; Su Z; Ma H; Ma H; Wei X; Du X
    Microb Pathog; 2018 May; 118():170-176. PubMed ID: 29571724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Zerumbone from Zingiber zerumbet Ameliorates Lipopolysaccharide-Induced ICAM-1 and Cytokines Expression via p38 MAPK/JNK-IκB/NF-κB Pathway in Mouse Model of Acute Lung Injury.
    Lee CY; Chen SP; Su CH; Ho YC; Yang ML; Lee SS; Huang-Liu R; Yang CP; Chen CJ; Kuan YH
    Chin J Physiol; 2018 Jun; 61(3):171-180. PubMed ID: 29962177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The protective effect of dexmedetomidine on LPS-induced acute lung injury through the HMGB1-mediated TLR4/NF-κB and PI3K/Akt/mTOR pathways.
    Meng L; Li L; Lu S; Li K; Su Z; Wang Y; Fan X; Li X; Zhao G
    Mol Immunol; 2018 Feb; 94():7-17. PubMed ID: 29241031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Silencing Angiopoietin-Like Protein 4 (ANGPTL4) Protects Against Lipopolysaccharide-Induced Acute Lung Injury Via Regulating SIRT1 /NF-kB Pathway.
    Guo L; Li S; Zhao Y; Qian P; Ji F; Qian L; Wu X; Qian G
    J Cell Physiol; 2015 Oct; 230(10):2390-402. PubMed ID: 25727991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 46.